Smad7 Promotes and Enhances Skeletal Muscle Differentiation

REFERENCES

• Amacher, S. L., J. N. Buskin, and S. D. Hauschka. 1993. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol. Cell. Biol. 13:2753–2764.
   PubMedGoogle Scholar
• Buckingham, M. 1992. Making muscle in mammals. Trends Genet. 8:144–148.
   PubMed Web of Science ®Google Scholar
• Camoretti-Mercado, B., D. J. Fernandes, S. Dewundara, J. Churchill, L. Ma, P. C. Kogut, J. F. McConville, M. S. Parmacek, and J. Solway. 10 May 2006, posting date. Inhibition of TGFβ-enhanced SRF-dependent transcription by SMAD7. J. Biol. Chem. [Online.] 10.1074/jbc.M602748200. [Epub ahead of print.]
   Google Scholar
• Carcamo, J., A. Zentella, and J. Massague. 1995. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol. 15:1573–1581.
   PubMedGoogle Scholar
• Choy, L., J. Skillington, and R. Derynck. 2000. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J. Cell Biol. 149:667–682.
   PubMed Web of Science ®Google Scholar
• Cox, D. M., M. Du, M. Marback, E. C. Yang, J. Chan, K. W. Siu, and J. C. McDermott. 2003. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J. Biol. Chem. 278:15297–15303.
   PubMedGoogle Scholar
• Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987–1000.
   PubMed Web of Science ®Google Scholar
• Donoviel, D. B., M. A. Shield, J. N. Buskin, H. S. Haugen, C. H. Clegg, and S. D. Hauschka. 1996. Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol. Cell. Biol. 16:1649–1658.
   PubMed Web of Science ®Google Scholar
• Emerson, C. P., Jr. 1993. Embryonic signals for skeletal myogenesis: arriving at the beginning. Curr. Opin. Cell Biol. 5:1057–1064.
   PubMedGoogle Scholar
• Ewton, D. Z., and J. R. Florini. 1990. Effects of insulin-like growth factors and transforming growth factor-beta on the growth and differentiation of muscle cells in culture. Proc. Soc. Exp. Biol. Med. 194:76–80.
   PubMedGoogle Scholar
• Florini, J. R., D. Z. Ewton, and K. A. Magri. 1991. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 53:201–216.
   PubMed Web of Science ®Google Scholar
• Forbes, D., M. Jackman, A. Bishop, M. Thomas, R. Kambadur, and M. Sharma. 2006. Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism. J. Cell. Physiol. 206:264–272.
   PubMedGoogle Scholar
• Gonzalez-Cadavid, N. F., W. E. Taylor, K. Yarasheski, I. Sinha-Hikim, K. Ma, S. Ezzat, R. Shen, R. Lalani, S. Asa, M. Mamita, G. Nair, S. Arver, and S. Bhasin. 1998. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc. Natl. Acad. Sci. USA 95:14938–14943.
   PubMed Web of Science ®Google Scholar
• Hata, A., G. Lagna, J. Massague, and A. Hemmati-Brivanlou. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12:186–197.
   PubMedGoogle Scholar
• Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y. Y. Xu, B. W. Grinnell, M. A. Richardson, J. N. Topper, M. A. Gimbrone, Jr., J. L. Wrana, and D. Falb. 1997. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89:1165–1173.
   PubMed Web of Science ®Google Scholar
• Hua, X., Z. A. Miller, H. Benchabane, J. L. Wrana, and H. F. Lodish. 2000. Synergism between transcription factors TFE3 and Smad3 in transforming growth factor-beta-induced transcription of the Smad7 gene. J. Biol. Chem. 275:33205–33208.
   PubMed Web of Science ®Google Scholar
• Javelaud, D., V. Delmas, M. Moller, P. Sextius, J. Andre, S. Menashi, L. Larue, and A. Mauviel. 2005. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene 24:7624–7629.
   PubMed Web of Science ®Google Scholar
• Jonckheere, N., M. Perrais, C. Mariette, S. K. Batra, J. P. Aubert, P. Pigny, and I. Van Seuningen. 2004. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Oncogene 23:5729–5738.
   PubMed Web of Science ®Google Scholar
• Joulia, D., H. Bernardi, V. Garandel, F. Rabenoelina, B. Vernus, and G. Cabello. 2003. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp. Cell Res. 286:263–275.
   PubMed Web of Science ®Google Scholar
• Kambadur, R., M. Sharma, T. P. Smith, and J. J. Bass. 1997. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res. 7:910–916.
   PubMed Web of Science ®Google Scholar
• Kavsak, P., R. K. Rasmussen, C. G. Causing, S. Bonni, H. Zhu, G. H. Thomsen, and J. L. Wrana. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6:1365–1375.
   PubMed Web of Science ®Google Scholar
• Lalani, R., S. Bhasin, F. Byhower, R. Tarnuzzer, M. Grant, R. Shen, S. Asa, S. Ezzat, and N. F. Gonzalez-Cadavid. 2000. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J. Endocrinol. 167:417–428.
   PubMed Web of Science ®Google Scholar
• Langley, B., M. Thomas, A. Bishop, M. Sharma, S. Gilmour, and R. Kambadur. 2002. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277:49831–49840.
   PubMed Web of Science ®Google Scholar
• Lassar, A. B., S. X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788–794.
   PubMed Web of Science ®Google Scholar
• Lee, K.-S., H.-J. Kim, Q.-L. Li, X.-Z. Chi, C. Ueta, T. Komori, J. M. Wozney, E.-G. Kim, J.-Y. Choi, H.-M. Ryoo, and S.-C. Bae. 2000. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 20:8783–8792.
   PubMed Web of Science ®Google Scholar
• Lee, S. J. 2004. Regulation of muscle mass by myostatin. Annu. Rev. Cell Dev. Biol. 20:61–86.
   PubMed Web of Science ®Google Scholar
• Liu, D., B. L. Black, and R. Derynck. 2001. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15:2950–2966.
   PubMed Web of Science ®Google Scholar
• Martin, J. S., M. C. Dickson, F. M. Cousins, A. B. Kulkarni, S. Karlsson, and R. J. Akhurst. 1995. Analysis of homozygous TGF beta 1 null mouse embryos demonstrates defects in yolk sac vasculogenesis and hematopoiesis. Ann. N. Y. Acad. Sci. 752:300–308.
   PubMedGoogle Scholar
• Massague, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753–791.
   PubMed Web of Science ®Google Scholar
• Massague, J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169–178.
   PubMed Web of Science ®Google Scholar
• Massague, J., S. Cheifetz, T. Endo, and B. Nadal-Ginard. 1986. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83:8206–8210.
   PubMed Web of Science ®Google Scholar
• McDermott, J. C., M. C. Cardoso, Y. T. Yu, V. Andres, D. Leifer, D. Krainc, S. A. Lipton, and B. Nadal-Ginard. 1993. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol. 13:2564–2577.
   PubMed Web of Science ®Google Scholar
• McPherron, A. C., and S. J. Lee. 1997. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA 94:12457–12461.
   PubMed Web of Science ®Google Scholar
• Molkentin, J. D., and E. N. Olson. 1996. Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 6:445–453.
   PubMed Web of Science ®Google Scholar
• Moustakas, A. 2002. Smad signalling network. J. Cell Sci. 115:3355–3356.
   PubMedGoogle Scholar
• Nakao, A., M. Afrakhte, A. Moren, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin, and P. ten Dijke. 1997. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389:631–635.
   PubMed Web of Science ®Google Scholar
• Olson, E. N., and W. H. Klein. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1–8.
   PubMed Web of Science ®Google Scholar
• Ornatsky, O. I., and J. C. McDermott. 1996. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells. J. Biol. Chem. 271:24927–24933.
   PubMedGoogle Scholar
• Overbergh, L., D. Valckx, M. Waer, and C. Mathieu. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305–312.
   PubMed Web of Science ®Google Scholar
• Perry, R. L., M. H. Parker, and M. A. Rudnicki. 2001. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8:291–301.
   PubMed Web of Science ®Google Scholar
• Pirskanen, A., J. C. Kiefer, and S. D. Hauschka. 2000. IGFs, insulin, Shh, bFGF, and TGF-beta1 interact synergistically to promote somite myogenesis in vitro. Dev. Biol. 224:189–203.
   PubMedGoogle Scholar
• Puri, P. L., and V. Sartorelli. 2000. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J. Cell. Physiol. 185:155–173.
   PubMed Web of Science ®Google Scholar
• Quinn, Z. A., C. C. Yang, J. L. Wrana, and J. C. McDermott. 2001. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res. 29:732–742.
   PubMedGoogle Scholar
• Rebbapragada, A., H. Benchabane, J. L. Wrana, A. J. Celeste, and L. Attisano. 2003. Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis. Mol. Cell. Biol. 23:7230–7242.
   PubMed Web of Science ®Google Scholar
• Schofield, J. N., and L. Wolpert. 1990. Effect of TGF-beta 1, TGF-beta 2, and bFGF on chick cartilage and muscle cell differentiation. Exp. Cell Res. 191:144–148.
   PubMed Web of Science ®Google Scholar
• Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693–699.
   PubMed Web of Science ®Google Scholar
• Stopa, M., D. Anhuf, L. Terstegen, P. Gatsios, A. M. Gressner, and S. Dooley. 2000. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. The TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J. Biol. Chem. 275:29308–29317.
   PubMed Web of Science ®Google Scholar
• Taylor, W. E., S. Bhasin, J. Artaza, F. Byhower, M. Azam, D. H. Willard, Jr., F. C. Kull, Jr., and N. Gonzalez-Cadavid. 2001. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 280:E221–E228.
   PubMed Web of Science ®Google Scholar
• Topper, J. N., J. Cai, Y. Qiu, K. R. Anderson, Y. Y. Xu, J. D. Deeds, R. Feeley, C. J. Gimeno, E. A. Woolf, O. Tayber, G. G. Mays, B. A. Sampson, F. J. Schoen, M. A. Gimbrone, Jr., and D. Falb. 1997. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA 94:9314–9319.
   PubMed Web of Science ®Google Scholar
• Wrana, J. L. 2000. Regulation of Smad activity. Cell 100:189–192.
   PubMedGoogle Scholar
• Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X. F. Wang, and J. Massague. 1992. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003–1014.
   PubMed Web of Science ®Google Scholar
• Wu, Z., P. J. Woodring, K. S. Bhakta, K. Tamura, F. Wen, J. R. Feramisco, M. Karin, J. Y. Wang, and P. L. Puri. 2000. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20:3951–3964.
   PubMed Web of Science ®Google Scholar
• Yu, Y. T., R. E. Breitbart, L. B. Smoot, Y. Lee, V. Mahdavi, and B. Nadal-Ginard. 1992. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6:1783–1798.
   PubMed Web of Science ®Google Scholar
• Zhu, X., S. Topouzis, L. F. Liang, and R. L. Stotish. 2004. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26:262–272.
   PubMed Web of Science ®Google Scholar